What class of medication is primarily used to reduce inflammation in the airways?

Corticosteroids are primarily used to reduce inflammation in the airways due to their powerful anti-inflammatory properties. These medications work by suppressing the immune response, thereby decreasing the release of inflammatory mediators such as cytokines and leukotrienes.

In respiratory therapy, corticosteroids are commonly prescribed for conditions like asthma and chronic obstructive pulmonary disease (COPD) where airway inflammation is a significant contributor to symptoms and exacerbations. By managing inflammation effectively, corticosteroids help improve airway function, reduce mucus production, and ultimately enhance the overall respiratory health of patients.

While other classes of medications, such as beta-agonists, anticholinergics, and leukotriene receptor antagonists, also play roles in treating respiratory conditions, their primary actions differ significantly from reducing inflammation. Beta-agonists primarily work as bronchodilators to relax airway muscles, anticholinergics block acetylcholine to reduce secretions and bronchodilate, and leukotriene receptor antagonists prevent leukotriene action but do not directly reduce inflammation like corticosteroids do. Thus, corticosteroids stand out as the primary choice for addressing inflammation in the airways.